Department of Oncology, Beatson University, Glasgow, UK
Mini Review
Stress Signature Score and Molecular Subtypes in Bulk Tumor Samples
Author(s): Viola Paulus*
Pancreatic ductal adenocarcinoma (PDAC), the more common form of pancreatic cancer (PC), is dominated by mutations in four well-known
cancer genes (KRAS, TP53, CDKN2A, and SMAD4). Pancreatic cancer (PC) has recently overtaken breast cancer to become the third leading
cause of cancer death in the United States1, and it is predicted to become the second leading cause within a decade. Biomarkers that predict
response to novel and established treatments are urgently needed and must extend beyond the detection of point mutations in coding genes
and low-prevalence actionable genomic events in order to better select patients for clinical trials. This diversity may explain the lack of progress
with targeted therapies because actionable genomic events being targeted therapeutically are present in only a small proportion of unselected
participants in clinical trials. To .. Read More»
DOI:
10.37421/1948-5956.2023.15.582
Cancer Science & Therapy received 5332 citations as per Google Scholar report